of one of the other vaccines? what's the most important thing that you're looking for out of this meeting? >> well, i think, john, probably the most important thing is to see whether the advisory committeeers on the side of uniformity, harmonization of approaches between the vaccines, or do they individualize? these action evens are all a little bit different from one know, and they may require different approaches to boosters. and -- and the moderna vaccine, for example, we think of as almost -- we had thought of as almost interchangeable with the pfizer vaccines but we've seen that over time it has been more durable in the protection that it offers. so does the committee say, well, let's go ahead and offer boosters for the moderna vaccine in the same way that we have the pfizer vaccine, or do we hold off a few more months and see exactly how good that durability is? similarly the johnson & johnson vaccine, of course, an entirely different technology, do we go ahead and boost the johnson &